NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Oral Antivirals for High-Risk COVID-19 Patients

Comparative therapeutic efficacy of remdesivir and combination

COVID-19 and Pregnancy: Risks and Outcomes - Nursing for Women's

Diagnosis and management of covid-19 in pregnancy

Remdesivir Fails to Prevent Covid-19 Deaths in Huge Trial - The

Remdesivir COVID-19 Treatment Guidelines

Infectious Disease Reports, Free Full-Text

Remdesivir against COVID-19 and Other Viral Diseases

Remdesivir for the Treatment of Covid-19 — Final Report

Therapeutic dilemmas in addressing SARS-CoV-2 infection

Cureus Compassionate Use of Remdesivir in Pregnancy: A Case

SARS-CoV-2 infection in pregnancy: A systematic review and meta